Susumu Maeda

Title: The Innovations of Susumu Maeda

Introduction

Susumu Maeda is a notable inventor based in Pasadena, California. He has made significant contributions to the field of biotechnology, particularly in the area of apoptosis regulation. With a total of four patents to his name, Maeda's work has implications for various medical applications.

Latest Patents

One of Maeda's latest patents is titled "Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them." This invention provides polypeptides comprising inhibitor of apoptosis protein (IAP) family members, such as BmIAP, which is initially derived from BmN cells. The patent also includes nucleic acids encoding these proteins and methods for making and using these compositions, including their application for inhibiting apoptosis. This innovative work has the potential to advance therapeutic strategies in treating diseases where apoptosis plays a critical role.

Career Highlights

Throughout his career, Susumu Maeda has worked with esteemed institutions, including the University of California. His research has focused on the mechanisms of apoptosis and how they can be manipulated for therapeutic benefits. His contributions to the field have been recognized through his patents, which reflect his commitment to advancing scientific knowledge.

Collaborations

Maeda has collaborated with notable colleagues such as Bruce D. Hammock and Qihong Huang. These partnerships have likely enriched his research and contributed to the successful development of his patented technologies.

Conclusion

In summary, Susumu Maeda is a distinguished inventor whose work in apoptosis regulation has led to valuable patents. His innovative contributions continue to influence the field of biotechnology and hold promise for future medical advancements.